Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Ellen M. Apperloo, Hiddo J.L. Heerspink, Secundino Cigarrán Guldris et al.|Nature Medicine|2024

Cited by 95